Hanno, Japan

Yoshimitsu Suda



Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Tokorozawa, JP (1999 - 2006)
  • Hanno, JP (2010 - 2012)

Company Filing History:


Years Active: 1999-2012

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations of Yoshimitsu Suda

Introduction

Yoshimitsu Suda is a prominent inventor based in Hanno, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing antitumor agents. With a total of 6 patents to his name, Suda's work focuses on innovative compounds that aim to improve cancer treatment while minimizing side effects.

Latest Patents

Suda's latest patents include an acylthiourea compound or salt thereof, which serves as a c-Met inhibitory antitumor agent. This compound selectively targets tumor cells expressing c-Met, thereby reducing side effects associated with traditional treatments. Another notable patent is for a bis(trimethylsilyl)phenyl compound or salt thereof, which exhibits excellent antitumor effects while reducing skin disorders linked to existing retinoids. This compound selectively activates the nuclear receptor RARα, potentially leading to significant clinical benefits.

Career Highlights

Yoshimitsu Suda is affiliated with Taiho Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for cancer treatment, showcasing his dedication to improving patient outcomes.

Collaborations

Suda has collaborated with notable colleagues, including Tetsuji Asao and Tomohiro Yamashita. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical innovations.

Conclusion

Yoshimitsu Suda's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing cancer treatment. His work not only aims to improve efficacy but also to reduce the adverse effects of existing therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…